Qiming Venture Partners

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore, and a global arm through Qiming Venture Partners USA. It manages multiple funds and invests in early and growth-stage companies across technology, information technology, healthcare, new consumer sectors, AI, robotics, semiconductors, software and digital health. The firm emphasizes a hands-on approach, often taking board seats and providing operational guidance to help CEOs scale and reach exits. Through its investments, it has backed hundreds of companies and supported numerous IPOs and M&A outcomes, with unicorns among its portfolio, illustrating breadth and depth across China and international markets.

Artavazd Arumov Ph.D

Principal

Cyrus Chan

Associate

Nan Chen

Principal

David Chu

Partner

Phillip DiGiacomo Ph.D

Principal

Past deals in Technology

Weimei Health

Series A in 2025
Weimei Health is a provider of smart solutions for medical information technology

Singular Medical

Series C in 2025
Singular Medical is a technology company focused on the research and development of cardiac rhythm management (CRM) products. It specializes in designing and industrializing a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. By creating a complete technical platform, Singular Medical offers solutions that encompass the entire patient journey, from initial detection of cardiac issues to ongoing follow-up care. The company's commitment to providing reliable and professional medical equipment aims to enhance the quality of care for patients with various cardiac conditions.

Pulnovo Medical

Series C in 2025
Pulnovo Medical, established in 2013 in Wuxi, Anhui, is focused on the development, production, and service provision of innovative medical technologies. The company specializes in creating advanced equipment for treating pulmonary hypertension, particularly through the use of pulse radiofrequency ablation technology. Its core products include pioneering high-frequency ablation equipment and intravascular catheters, which are protected by global invention patents. Pulnovo Medical aims to enhance the quality of life for patients suffering from pulmonary hypertension and heart failure by offering cutting-edge treatment solutions.

DH-Robotics

Venture Round in 2025
DH Robotics Technology Co., Ltd., founded in 2016 and based in China, specializes in the research and development of robotic hands and industrial robots. The company focuses on creating electric gripping jaws intended to enhance intelligent manufacturing processes. Its products are designed to be stable, secure, and easily integrated, catering to the needs of advanced manufacturing and lean production. By developing cost-effective solutions, DH Robotics aims to support flexible and intelligent demands within the manufacturing sector.

Stairway Medical

Series B in 2025
Stairway Medical is a ladder of human progress and evolution stairs up for human health. The technology and products will be applicable to medical scenarios such as human function restoration, disease treatment, and functional enhancement, as well as related scientific research work.

Xi'an Dunbo Medical Equipment

Series A in 2025
Xi'an Dunbo Medical Equipment focuses on the research, development, and production of AI medical devices. The products currently under development are cardiac pacemakers and brain pacemakers, Cardiac defibrillators. Self-developed products include chips, hardware circuits, software application systems, and structural materials.

Zhipu AI

Venture Round in 2024
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Soda Health

Series B in 2024
Founded in 2021, Soda Health is a Chicago-based healthcare technology company committed to reducing health disparities by addressing social determinants of health. It operates a platform that delivers personalized benefits, providing real-time access to essential services such as healthy food, over-the-counter medications, and transportation.

Dearer Medical

Venture Round in 2024
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.

IntoCare

Series D in 2024
IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Zhipu AI

Series D in 2024
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

SPEEDIANCE

Series B in 2024
Speediance designs and operates smart at-home fitness equipment for strength training and provides an online platform with training guidance and strength-training courses, connecting individual users with a workout community and resources to improve home workouts.

Guangjing Energy

Series A in 2024
Guangjing Energy specializes in the R&D and mass production of durable, large-area perovskite solar cell modules. They develops perovskite film printing technology with independent intellectual property rights and realized the preparation of large-area perovskite components.

CSR Biotech

Series A in 2024
CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.

SonoSilicon

Angel Round in 2024
SonoSilicon researches on medical-grade micro-on-chip ultrasound systems and chip design and promotes the medical device industry.

DK Medtech

Series E in 2024
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.

Novamab

Series B in 2024
Novamab is a biotechnology company specializing in the development of novel nanobodies, a type of single-domain antibody with unique therapeutic advantages. With over 15 years of experience in nanobody research and development, the company's team of pioneers in this field has established platforms to maximize the potential of nanobodies. Novamab focuses on creating innovative drug formulations such as inhaled macromolecular drugs, albumin nanobody long-acting therapies, and nanobody double-antibody combinations. Their primary goal is to address unmet clinical needs by improving administration methods and reducing treatment cycles for major chronic diseases like cancer, autoimmune disorders, and cardiovascular conditions.

Jiakekangnuo Bio

Angel Round in 2024
Jiakekangnuo Bio focuse on technology, promote industrial incubation through strategic investment, and achieves commercialization.

CureGenetics

Series B in 2024
CureGenetics is a biotechnology company focused on advancing innovative medicines and molecular diagnostics through the application of gene editing technologies. The company specializes in the research and development of solutions aimed at the treatment of cancers and genetic diseases. CureGenetics is dedicated to creating next-generation therapies that enhance patient outcomes by leveraging cutting-edge techniques in gene editing and delivery platforms. Through its efforts, the company aims to contribute significantly to the field of personalized medicine and improve treatment options for complex health conditions.

Chunyu Yisheng

Venture Round in 2024
Chunyu Yisheng, established in 2011 and headquartered in Beijing, is a mobile application designed to enhance communication between physicians and patients. The app allows doctors to access their patients' medical records and facilitates direct interaction, enabling patients to schedule appointments and communicate with their healthcare providers. Additionally, Chunyu Yisheng offers reservation line treatment services, further supporting users in managing their health. The company focuses on leveraging Internet technology to improve health outcomes and streamline the healthcare experience.

Zhipu AI

Series B in 2024
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Alamar Biosciences

Series C in 2024
Alamar Biosciences, founded in 2018 and headquartered in Fremont, California, specializes in developing advanced technologies for the early detection and treatment of cancer and other diseases. The company focuses on a precision proteomics platform that facilitates protein analysis and the creation of antibody technologies. This platform is designed to enhance the diagnosis of diseases, particularly cancer, while also supporting the discovery of new biomarkers. By enabling healthcare providers to detect diseases at an early stage, Alamar Biosciences aims to improve patient outcomes through timely interventions and potential cures.

DH-Robotics

Series C in 2024
DH Robotics Technology Co., Ltd., founded in 2016 and based in China, specializes in the research and development of robotic hands and industrial robots. The company focuses on creating electric gripping jaws intended to enhance intelligent manufacturing processes. Its products are designed to be stable, secure, and easily integrated, catering to the needs of advanced manufacturing and lean production. By developing cost-effective solutions, DH Robotics aims to support flexible and intelligent demands within the manufacturing sector.

Jasper Therapeutics

Post in 2024
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company based in Menlo Park, California, that specializes in developing therapeutic agents for hematopoietic stem cell transplants and gene therapies. Founded in 2018, the company aims to enhance the safety and efficacy of conditioning agents to broaden the application of curative therapies. Jasper's lead product, JSP191, is a humanized monoclonal antibody currently in clinical development, designed to act as a conditioning agent by selectively clearing hematopoietic stem cells from bone marrow in patients undergoing stem cell transplants. The company also utilizes an engineered hematopoietic stem cells platform to address the limitations of transplant grafts, thereby increasing the accessibility of both allogeneic and autologous gene-edited hematopoietic stem cell therapies for a larger patient population.

Magair Chemical

Series A in 2024
Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, and significantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.

Supermag

Series A in 2024
Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as Suci Technology) is committed to the research and development, production and sales of maglev high-speed motors. With the design authorization of magnetic levitation compressors, magnetic levitation blowers, magnetic levitation pumps, etc., it provides core components such as magnetic levitation motors, magnetic levitation bearings, magnetic levitation controllers, and displacement sensors.

ACXEL

Series A in 2024
ACXEL Tech specializes in developing advanced large-area electronics that enable innovative applications in drug discovery and biological research. The company's proprietary digital microfluidic platform utilizes millions of 'active' pixels to manipulate liquid droplets with high precision and speed. This technology serves as a programmable and cost-effective solution for various applications, including fundamental bio-related research, cell line development, cell therapy, synthetic biology, and antibody therapy. By allowing clients to conduct complex experimental procedures at the single-cell level, ACXEL enhances productivity and efficiency within the fields of chemistry, biology, and medtech.

ABUP

Series B in 2023
ABUP specializes in over-the-air (OTA) technology solutions for the automotive and Internet of Things (IoT) sectors. The company delivers a range of products that include firmware upgrades, software upgrades, and cloud diagnosis services tailored for vehicles and IoT devices. By leveraging artificial intelligence and big data, ABUP enables its clients to enhance their offerings, ensuring that products remain current and provide users with a customized experience. The company's solutions are designed to support original equipment manufacturers (OEMs) in managing OTA systems effectively, facilitating continuous innovation and personalized service within the rapidly evolving landscape of connected technologies.

Sanegene Bio

Series A in 2023
Sanegene Bio is a biotechnology company focused on developing RNA interference (RNAi) therapeutics aimed at addressing unmet clinical needs across various therapeutic areas. Its innovative RNAi drug discovery platform targets disease-causing genes, effectively knocking them down to provide potential treatments for conditions such as cardiovascular and metabolic diseases, immunology-related disorders, and diseases affecting the nervous system. By leveraging advanced RNA technology, Sanegene Bio is capable of achieving specific delivery of multiple RNA drugs, enhancing the effectiveness of its therapeutic offerings for patients suffering from a range of health issues, including infectious diseases and eye conditions.

Jiiov Technology

Venture Round in 2023
Jiiov Technology is a provider of biometric recognition solutions specializing in fingerprint identification products tailored for intelligent terminals. The company develops advanced algorithms for artificial intelligence-driven fingerprint recognition, including innovative extreme finger fingerprint algorithms. In addition to algorithm development, Jiiov Technology focuses on professional sensor design, optical design, module design, and specialized computing. This comprehensive suite of offerings enables effective law and software integration, enhancing the fingerprint capabilities of intelligent terminal devices.

CSR Biotech

Series A in 2023
CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.

Saints & Sages

Series B in 2023
Saints & Sages Medical specializes in the development and production of minimally invasive surgical medical devices. The company offers a range of energy devices that are utilized across various medical fields, including hepatobiliary, gynecology, urology, thoracic surgery, thyroid and breast surgery, and gastrointestinal surgery. With a commitment to addressing clinical needs, Saints & Sages focuses on innovation in surgical technology. They leverage a dedicated research and development team and extensive clinical experience to create devices that enhance the precision and efficiency of surgical procedures, ultimately aiming to improve patient outcomes globally.

Zhipu AI

Series B in 2023
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Guangjing Energy

Series A in 2023
Guangjing Energy specializes in the R&D and mass production of durable, large-area perovskite solar cell modules. They develops perovskite film printing technology with independent intellectual property rights and realized the preparation of large-area perovskite components.

Puanita

Series A in 2023
Puanita is a pet medicine brand seeking development with science and technology for pets. Puanita is headquartered in China.

CIX Technology

Series A in 2023
CIX Technology is a developer of high-performance, next-generation intelligent computing solutions, specializing in the creation of general-purpose intelligent computing chips and computer CPUs. The company focuses on energy-efficient computing technologies that utilize ARM architecture. Its chips are designed for terminal general intelligent computing applications, including notebooks, desktops, high-end tablets, and augmented and virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to produce advanced electronics and other products, ultimately increasing the speed and efficiency of computing across various scenarios.

Cloud Technology

Venture Round in 2023
Cloud Technology is a multi-cloud and integrated data platform provider.

HOUMO.AI

Series A in 2023
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that deliver substantial computing power while maintaining low energy consumption, thereby enabling enterprises to create advanced AI-integrated electronics and intelligent robotics products at competitive prices. By leveraging disruptive technologies, Houmo.AI aims to address the growing demand for computing power in the realm of true artificial intelligence, striving to revolutionize the industry with its innovative solutions.

IntoCare

Series D in 2023
IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

CuroVax

Series B in 2023
CuroVax, established in 2011 and headquartered in Changzhou City, China, specializes in vaccine development and production. The company offers a range of vaccines, including a freeze-dried rabies vaccine for human use and an influenza virus split vaccine. CuroVax employs a dual approach of independent development and collaborative research, supported by multiple technology platforms such as large-scale mammalian cell culture and mRNA vaccine development. It provides biotechnology and microbiology services, focusing on improving health and medical industry standards.

DK Medtech

Venture Round in 2023
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.

Zeen Health

Series A in 2023
Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.

Caidya

Series D in 2023
Caidya is a North Carolina-based clinical research organization that provides personalized solutions across therapeutic areas. It operates and develops a proprietary technology platform that integrates data from diverse systems to deliver near real-time visibility into clinical trials. Founded in 2021, Caidya offers advisory services on clinical development plans, regulatory strategies, approval processes, and trial execution, helping pharmaceutical and biotechnology companies globalize development, improve trial efficiency, and increase the likelihood of product success.

Puanita

Pre Seed Round in 2023
Puanita is a pet medicine brand seeking development with science and technology for pets. Puanita is headquartered in China.

moodytiger

Convertible Note in 2023
moodytiger is a technical athletic apparel brand for children from age of 4 to 16. Today, kids from more than 100 countries, from United States to Australia, from Singapore to Hong Kong, have worn moodytiger outfits in their wonderful active adventure! Born to redefine kids’ athlectic wear from day one, our products are specially tailored for children with perfect combination of high-tech fabrics and fashion-forward designs, and functionally suited for multiple sports, including tennis, skiing, skating, swimming, outdoor, and everyday active living. As one of the fastest growing and most innovative brands in the category, we thrive to be the new industry benchmark setter with what we do.

Ricoton

Series A in 2023
Ricoton is a medical device company based in Hunan, China, specializing in the development and production of devices for cerebrovascular diseases. Founded in 2011, the company offers a range of products designed for interventional medicine, including microcatheters, guidewires, and various vascular access devices. Notably, Ricoton's equipment features a comprehensive set that includes a micro guide wire, micro catheter, support catheter, thrombectomy stent, balloon guide catheter, and intracranial balloon dilatation catheter. This innovative lineup provides a one-stop thrombectomy solution aimed at enhancing the treatment and prevention of cerebrovascular conditions.

Jiangsu Jing Chuang Advanced Electronic Technology

Series B in 2023
Jiangsu Jing Chuang Advanced Electronic Technology focuses on the research and development of equipment for the semiconductor manufacturing sector. The company specializes in high-precision grinding machines and offers a range of products, including automatic laser saws, dicing saws, and wafer cleaning equipment. By providing comprehensive solutions for semiconductor material dicing applications, Jing Chuang Advanced aims to support the growing demands of the semiconductor industry.

Scroll.io

Venture Round in 2023
Scroll, founded in 2021 and based in Victoria, Seychelles, is focused on developing an EVM-equivalent zk-rollup, which utilizes a robust proving network. The company operates within the technology sector, with an emphasis on enhancing blockchain scalability and efficiency. By leveraging zero-knowledge proof technology, Scroll aims to facilitate faster and more secure transactions on decentralized applications. The firm's innovative approach positions it as a key player in the evolving landscape of blockchain infrastructure.

Frontis

Angel Round in 2023
Frontis is a technology company that specializes in artificial intelligence solutions tailored for businesses in the fast-moving consumer goods, consumer electronics, and beauty sectors. The company develops demand planning software that assists clients in forecasting product demand, enabling them to align their offerings with consumer needs effectively. Additionally, Frontis provides comprehensive services, including 3C product planning, performance monitoring for product launches, and digital transformation solutions. By leveraging advanced technology, Frontis aims to enhance the connection between businesses and their consumers, delivering valuable insights that drive informed decision-making and strategic planning.

Hochuen Medical

Series B in 2023
Hochuen Medical USA Corp., established in 2015 by industry veterans Dr. Robin Liu and Eric Zeng, specializes in the design, development, and mass production of medical devices and consumables as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM). The company focuses on In Vitro Diagnostics (IVD), wearable medical technology, and microfluidic devices, with a portfolio including COVID-19 testing kits and various medical disposables. Hochuen Medical operates as a Contract Development and Manufacturing Organization (CDMO), producing high-quality products such as microfluidic biochips, IVD disposable consumables, point-of-care testing kits, and gene sequencing chips for clients worldwide. The company is committed to quality, holding FDA registration and ISO certifications, and aims to contribute innovative solutions to the healthcare industry through continuous research and development.

Singular Medical

Series B in 2023
Singular Medical is a technology company focused on the research and development of cardiac rhythm management (CRM) products. It specializes in designing and industrializing a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. By creating a complete technical platform, Singular Medical offers solutions that encompass the entire patient journey, from initial detection of cardiac issues to ongoing follow-up care. The company's commitment to providing reliable and professional medical equipment aims to enhance the quality of care for patients with various cardiac conditions.

Insyce

Series B in 2023
Insyce creates equipment and apparatus for science. Its business strives to provide tools and technology for bio labs that monitor the environment to deliver accurate data and speedy chemical analysis while keeping lab costs down for their clients. It is dedicated to providing upper biological separation equipment and chemical analysis tools for global clients, cutting down on client operating expenses, and adding value for clients.

Biotree Technology

Series A in 2023
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.

Tlibrium

Angel Round in 2022
Tlibrium provides expertise in the technology promotion and application service industry. Tlibrium was founded in 2022 and was headquartered in Shanghai, China.

Bio-Link

Series A in 2022
Bio-Link is a drug development company founded in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, including the development and manufacturing of key process equipment and consumables. Bio-Link's offerings include technologies for vaccines, antibody drugs, cell therapy, gene therapy, and various biologics. The company focuses on upstream cell culture, disposable dispensing reservoirs, and downstream processes such as chromatography and ultrafiltration. By delivering innovative products and services, Bio-Link aims to enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, the company explores wearable technology solutions for elderly care, further diversifying its portfolio.

Snarkify

Seed Round in 2022
Snarkify is a blockchain company that develops zero-knowledge-proof infrastructure and tools to enable secure authentication and scalable applications. Founded in 2022, the company provides a framework for developing, deploying, and scaling applications by using zero-knowledge proofs to verify information without revealing sensitive data and to summarize large data sets into compact proofs.

Sanegene Bio

Series A in 2022
Sanegene Bio is a biotechnology company focused on developing RNA interference (RNAi) therapeutics aimed at addressing unmet clinical needs across various therapeutic areas. Its innovative RNAi drug discovery platform targets disease-causing genes, effectively knocking them down to provide potential treatments for conditions such as cardiovascular and metabolic diseases, immunology-related disorders, and diseases affecting the nervous system. By leveraging advanced RNA technology, Sanegene Bio is capable of achieving specific delivery of multiple RNA drugs, enhancing the effectiveness of its therapeutic offerings for patients suffering from a range of health issues, including infectious diseases and eye conditions.

Bitworx

Series A in 2022
Bitworx is a technology company headquartered in Chengdu, China, specializing in product development and applications that leverage advanced algorithm and chip technology. The company's focus is on enhancing communication, sensing, and detection capabilities. Currently, Bitworx is operating in stealth mode, which indicates a strategic approach to its operations and product offerings, allowing for innovation and development away from public scrutiny. Through its expertise in cutting-edge technology, Bitworx aims to create solutions that meet emerging demands in various sectors.

Soda Health

Series A in 2022
Founded in 2021, Soda Health is a Chicago-based healthcare technology company committed to reducing health disparities by addressing social determinants of health. It operates a platform that delivers personalized benefits, providing real-time access to essential services such as healthy food, over-the-counter medications, and transportation.

CSR Biotech

Seed Round in 2022
CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.

Focallure

Series B in 2022
Focallure is a cosmetic company headquartered in Guangzhou, China, specializing in the development and manufacturing of makeup products. The company emphasizes base makeup and a variety of cosmetics, utilizing big data analysis to enhance its operations. By analyzing consumer product preferences and social content trends, Focallure aims to provide users with an innovative and refreshing makeup experience.

Prismlab China

Series C in 2022
Prismlab China Ltd. is a high-tech enterprise established in 2005, specializing in the development, production, and sales of high-speed light-curing 3D printers. The company integrates optical, mechanical, and electrical technology with computer software and hardware, alongside photopolymer materials. Prismlab's primary focus is on research and development, manufacturing, and marketing of rapid prototyping machines utilizing stereolithography (SLA) technology. Its innovative products are recognized for their quality and performance, reaching customers in over 50 countries and regions, and have garnered critical acclaim from users around the globe.

Scroll.io

Series B in 2022
Scroll, founded in 2021 and based in Victoria, Seychelles, is focused on developing an EVM-equivalent zk-rollup, which utilizes a robust proving network. The company operates within the technology sector, with an emphasis on enhancing blockchain scalability and efficiency. By leveraging zero-knowledge proof technology, Scroll aims to facilitate faster and more secure transactions on decentralized applications. The firm's innovative approach positions it as a key player in the evolving landscape of blockchain infrastructure.

Biren Technology

Series B in 2022
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors tailored for GPU and DSA computation architectures. The company focuses on creating integrated software and hardware platforms that support intelligent computing applications, including cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. With a dedicated team of industry experts and elite engineers, Biren Technology aims to deliver versatile computing solutions that blend general computing capabilities with specific applications. Its research division is committed to advancing key technologies in intelligent computing systems, emphasizing new architectures and advanced compilation techniques, thereby facilitating technological breakthroughs in various high-tech sectors.

OriginCell

Series B in 2022
Shanghai Origincell Biological Cryo Equipment Co., Ltd. is a biomedical enterprise established in 2014, headquartered in Shanghai, China. The company specializes in immunological cell collection, separation, and storage services. It manufactures biobanking storage devices, including cryogenic freezers and biobank systems. In addition to its storage solutions, Origincell develops tumor immunotherapy solutions, utilizing advanced technologies such as the 10-phage display library and humanized antibody technology. These innovations support medical facilities in their cancer treatment efforts, positioning Origincell as a key player in the intersection of biobanking and cancer therapy.

CIX Technology

Seed Round in 2022
CIX Technology is a developer of high-performance, next-generation intelligent computing solutions, specializing in the creation of general-purpose intelligent computing chips and computer CPUs. The company focuses on energy-efficient computing technologies that utilize ARM architecture. Its chips are designed for terminal general intelligent computing applications, including notebooks, desktops, high-end tablets, and augmented and virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to produce advanced electronics and other products, ultimately increasing the speed and efficiency of computing across various scenarios.

Biotree Technology

Series A in 2022
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.

Puanita

Angel Round in 2022
Puanita is a pet medicine brand seeking development with science and technology for pets. Puanita is headquartered in China.

Cubenergy Technology

Series B in 2022
Cubenergy Technology is an energy technology company specializing in energy data operation services and the integration of distributed energy storage systems. The company develops advanced energy management and storage systems that utilize data analysis to optimize performance and maintain system efficiency. By providing innovative solutions in energy management, Cubenergy Technology aims to enhance the operation of energy storage systems, ensuring that users achieve optimal control and performance in their energy applications.

Purevision

Seed Round in 2022
Purevision is a technological start-up company that focuses on innovative ophthalmic medical devices.

Ashermed

Series B in 2022
Ashermed is a provider of contract research organization (CRO) services specifically designed for medical companies. The company emphasizes the integration of advanced technologies, such as Internet technology, big data, and artificial intelligence, to enhance the drug development process. By leveraging these technologies, Ashermed aims to shorten the clinical data development cycle and improve the quality of research outcomes, ultimately reducing research and development costs for its clients. Their offerings include CRO services, site management organization (SMO) support, patient recruitment, and digital platform assistance, all tailored to facilitate the needs of the medical industry.

M20 Genomics

Seed Round in 2022
M20 Genomics is a life science and technology company focused on advancing single-cell sequencing technology and its applications. The company aims to establish itself as a global leader in next-generation single-cell technology for disease diagnosis and treatment. Its innovative single-cell sequencing platform is capable of detecting nearly 10,000 genes from individual cells or nuclei in various sample types, including fresh, frozen, and formalin-fixed paraffin-embedded specimens. This technology enables researchers to enhance the efficiency of their studies, particularly in bacterial research, by providing comprehensive data through full-length RNA sequencing.

CIX Technology

Angel Round in 2022
CIX Technology is a developer of high-performance, next-generation intelligent computing solutions, specializing in the creation of general-purpose intelligent computing chips and computer CPUs. The company focuses on energy-efficient computing technologies that utilize ARM architecture. Its chips are designed for terminal general intelligent computing applications, including notebooks, desktops, high-end tablets, and augmented and virtual reality systems. By enhancing processing power, CIX Technology enables enterprises to produce advanced electronics and other products, ultimately increasing the speed and efficiency of computing across various scenarios.

HOUMO.AI

Series A in 2022
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that deliver substantial computing power while maintaining low energy consumption, thereby enabling enterprises to create advanced AI-integrated electronics and intelligent robotics products at competitive prices. By leveraging disruptive technologies, Houmo.AI aims to address the growing demand for computing power in the realm of true artificial intelligence, striving to revolutionize the industry with its innovative solutions.

Clique

Seed Round in 2022
Clique coordinates diverse compute resources, allocating them dynamically for general applications and smart contracts. This includes co-processors for verifiable computing on-chain data, oracles for external data sources, and specialized hardware for privacy, AI, and secure computation.

ACXEL

Seed Round in 2022
ACXEL Tech specializes in developing advanced large-area electronics that enable innovative applications in drug discovery and biological research. The company's proprietary digital microfluidic platform utilizes millions of 'active' pixels to manipulate liquid droplets with high precision and speed. This technology serves as a programmable and cost-effective solution for various applications, including fundamental bio-related research, cell line development, cell therapy, synthetic biology, and antibody therapy. By allowing clients to conduct complex experimental procedures at the single-cell level, ACXEL enhances productivity and efficiency within the fields of chemistry, biology, and medtech.

Jiiov Technology

Series A in 2022
Jiiov Technology is a provider of biometric recognition solutions specializing in fingerprint identification products tailored for intelligent terminals. The company develops advanced algorithms for artificial intelligence-driven fingerprint recognition, including innovative extreme finger fingerprint algorithms. In addition to algorithm development, Jiiov Technology focuses on professional sensor design, optical design, module design, and specialized computing. This comprehensive suite of offerings enables effective law and software integration, enhancing the fingerprint capabilities of intelligent terminal devices.

MeetFuture

Series B in 2022
MeetFuture China is a technology-driven company specializing in automated transmission systems for the pan-semiconductor industry. Established in 2016, it offers innovative automation solutions aimed at enhancing industrial upgrading and development. The company leverages control theory, computer technology, and information systems to deliver effective industrial detection, control, optimization, dispatch, and management solutions. By implementing these advanced technologies, MeetFuture enables its clients to reduce operational costs and optimize production parameters, thereby improving overall efficiency and productivity in the semiconductor sector.

Zhipu AI

Series B in 2022
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Wowjoy Technology

Series A in 2022
Wowjoy Technology is a company based in Hangzhou, China, specializing in data-driven medical services. It offers an internet-based medical information platform designed to support large hospital groups and their patients. The company's solutions include various workstations, such as medical integrated workstations, imaging workstations, hospital laboratory workstations, and pharmacy service workstations. These services facilitate efficient information processing for diagnosis, treatment, and billing, ultimately enhancing the effectiveness of healthcare delivery.

Booming Technologies

Series D in 2022
Booming Tech is a cloud-based platform that specializes in game development and virtual reality. It provides tools for creators to design and innovate within virtual environments, catering to various applications, including gaming, industrial simulations, and other immersive experiences. The platform features a robust server architecture that ensures players can engage in real-time, stable interactions regardless of their geographical locations. By focusing on both entertainment and practical applications, Booming Tech supports a diverse range of virtual world creation, enabling users to explore new possibilities in digital interaction.

Deep View Technology

Series B in 2022
Deep View Technology specializes in motion capture and augmented reality (AR) and virtual reality (VR) applications. The company focuses on research and development in three-dimensional computer vision algorithms, utilizing wearable devices to identify and capture human gestures and postures in real time. This innovative approach enables clients to enhance their VR experiences by accurately translating physical movements into digital environments, thus facilitating a more immersive interaction with technology.

CureGenetics

Series B in 2022
CureGenetics is a biotechnology company focused on advancing innovative medicines and molecular diagnostics through the application of gene editing technologies. The company specializes in the research and development of solutions aimed at the treatment of cancers and genetic diseases. CureGenetics is dedicated to creating next-generation therapies that enhance patient outcomes by leveraging cutting-edge techniques in gene editing and delivery platforms. Through its efforts, the company aims to contribute significantly to the field of personalized medicine and improve treatment options for complex health conditions.

Yesmro

Series C in 2022
Yesmro, also known as Yimai Gongpin, is a retailer focused on providing small-business automation parts and industrial supplies. The company operates an e-commerce platform that caters to small- to medium-sized enterprises by offering a wide range of products, including electrical accessories, wires and cables, and industrial control components. Yesmro aims to make the procurement of industrial goods easier and more affordable for small businesses by leveraging technology and data-driven solutions. This commitment enables a broad spectrum of enterprises engaged in technological development to access essential industrial products conveniently and at a lower cost.

Frontis

Seed Round in 2021
Frontis is a technology company that specializes in artificial intelligence solutions tailored for businesses in the fast-moving consumer goods, consumer electronics, and beauty sectors. The company develops demand planning software that assists clients in forecasting product demand, enabling them to align their offerings with consumer needs effectively. Additionally, Frontis provides comprehensive services, including 3C product planning, performance monitoring for product launches, and digital transformation solutions. By leveraging advanced technology, Frontis aims to enhance the connection between businesses and their consumers, delivering valuable insights that drive informed decision-making and strategic planning.

Gemsouls

Series A in 2021
Gemsouls is an artificial intelligence company that develops technology to create virtual characters and facilitate their interactions with the real world. The platform aims to offer fans a novel way to engage with their favorite characters, enabling lasting connections with both fictional and real-life figures. By leveraging AI, Gemsouls enhances the experience of users, allowing them to stay connected to those they cherish, whether they are beloved characters from stories or significant individuals in their lives.

DP Technology

Series B in 2021
DPTechnology, founded in 2018 and based in Beijing, China, specializes in micro-scale industrial design through advanced molecular simulation technology. The company has developed a platform that integrates artificial intelligence with molecular simulation algorithms, aiming to enhance industrial and medical research. By providing users with innovative scientific tools, DPTechnology promotes efficiency and creativity in exploring complex research challenges, thereby establishing a new paradigm in both industrial research and clinical applications.

Yunji Technology

Venture Round in 2021
Yunji Technology is a Chinese robotics company specializing in the development and manufacture of service robots. These robots are designed to deliver goods commercially, improving efficiency and reducing costs for clients in industries such as hospitality, luxury retail, and restaurants.

SUPERHEXA

Series A in 2021
Superhexa is a Beijing-based hardware company founded on October 15, 2020, by Xia Yongfeng. The firm specializes in developing innovative personal consumer electronics designed to seamlessly integrate technology into everyday life. By focusing on enhancing user experiences, Superhexa aims to create products that cater to the evolving needs of consumers in a technology-driven world.

Tripod Preclinical Research

Venture Round in 2021
Tripod Preclinical Research is a Contract Research Organization that specializes in preclinical research services tailored for the biopharmaceutical industry. The company offers a comprehensive range of services, including nonhuman primate disease models, pharmacological efficacy assessments, early drug evaluations, and GLP toxicology. Tripod is committed to supporting global pharmaceutical companies, research and development enterprises, and medical device manufacturers in the evaluation of new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Additionally, the organization provides technology support in areas such as translational medicine, clinical trials, biological analysis, and the management of biological sample banks, ensuring that its clients have the necessary resources to advance their research and development efforts effectively.

Platelet BioGenesis

Series B in 2021
Platelet BioGenesis, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2014. It specializes in the production of donor-independent human platelets derived from pluripotent stem cells for clinical applications. The company has developed a microfluidic bioreactor that enables the generation of functional platelets at commercial scale from human stem cell cultures. These bioreactor-produced platelets are distributed to hospitals and blood banks, providing essential therapeutic resources to patients globally. Through its innovative approach, Platelet BioGenesis is contributing to advancements in biotechnology and the field of transfusion medicine.

Supermag

Series A in 2021
Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as Suci Technology) is committed to the research and development, production and sales of maglev high-speed motors. With the design authorization of magnetic levitation compressors, magnetic levitation blowers, magnetic levitation pumps, etc., it provides core components such as magnetic levitation motors, magnetic levitation bearings, magnetic levitation controllers, and displacement sensors.

Rox Motor

Series C in 2021
ROX Motor is a company dedicated to the development of off-road new energy vehicles, specializing in innovative technologies that enhance smart car capabilities. The firm focuses on research and development in several key areas, including new energy power systems, intelligent cockpit designs, and autonomous driving solutions. By providing advanced product definitions and core intelligence technologies, ROX Motor aims to improve the overall quality of products within the new energy vehicle industry, catering to the growing demand for environmentally friendly and technologically advanced transportation options.

GenLight Medical

Series B in 2021
GenLight Medical is a company based in Hangzhou, China, that specializes in developing innovative treatment solutions for epilepsy and other neurological disorders. The firm focuses on creating advanced laser medical equipment and technologies aimed at improving patient outcomes in the fields of brain science and neurosurgery. Among its notable advancements are brain-computer control technology, full-cranial implantation techniques for deep brain nerve stimulation, brain computer chips, and systems for magnetic resonance guided laser ablation, which facilitate minimally invasive surgical procedures. GenLight Medical is committed to providing high-end, technologically advanced solutions for patients requiring brain surgery.

Zeen Health

Venture Round in 2021
Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.

Atom Semiconductor

Venture Round in 2021
Atom Semiconductor is a scientific and technological enterprise focusing on digital sensor design. Atom Semiconductor was founded in 2020.

Genedit

Angel Round in 2021
GenEdit Inc., established in 2016 and headquartered in Berkeley, California, specializes in developing innovative genome editing tools. The company's core technology is CRISPR/Cas9, which enables precise therapeutic gene editing. GenEdit has further advanced this field by creating the NanoGalaxy™ platform, a proprietary non-viral delivery system that efficiently transports CRISPR/Cas9 to target tissues, overcoming previous delivery challenges. This platform systematically screens a library of nanoparticles to ensure safer and more effective delivery, making therapeutic gene editing easier, faster, and more accurate than traditional methods. GenEdit's ultimate goal is to facilitate the cure of previously incurable genetic diseases by providing physicians with powerful tools for gene therapy.

Okeanos Technology

Series B in 2021
Okeanos Technology specializes in the custom synthesis and production of specialized chemical biological reagents and pharmaceutical intermediates tailored for the life sciences sector. The company offers a diverse range of products, including modified nucleotides, unnatural amino acids, heterocycles, as well as fluorescent and labeling reagents. Okeanos serves prominent pharmaceutical companies, delivering high-quality chemical compounds and intermediates that support various applications in research and development. Renowned for its commitment to quality and innovation, Okeanos has established a strong reputation among its clients in the pharmaceutical industry.

Cubenergy Technology

Series A in 2021
Cubenergy Technology is an energy technology company specializing in energy data operation services and the integration of distributed energy storage systems. The company develops advanced energy management and storage systems that utilize data analysis to optimize performance and maintain system efficiency. By providing innovative solutions in energy management, Cubenergy Technology aims to enhance the operation of energy storage systems, ensuring that users achieve optimal control and performance in their energy applications.

Jasper Therapeutics

Post in 2021
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company based in Menlo Park, California, that specializes in developing therapeutic agents for hematopoietic stem cell transplants and gene therapies. Founded in 2018, the company aims to enhance the safety and efficacy of conditioning agents to broaden the application of curative therapies. Jasper's lead product, JSP191, is a humanized monoclonal antibody currently in clinical development, designed to act as a conditioning agent by selectively clearing hematopoietic stem cells from bone marrow in patients undergoing stem cell transplants. The company also utilizes an engineered hematopoietic stem cells platform to address the limitations of transplant grafts, thereby increasing the accessibility of both allogeneic and autologous gene-edited hematopoietic stem cell therapies for a larger patient population.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.